Careviso Raises Over $17 Million In Series B Funding To Enhance Transparency And Access For Diagnostic Testing

Sep 28, 2022•almost 3 years ago

Amount Raised

$17 Million

Round Type

series b

Falls ChurchMedicalHealth CareInformation Technology

Description

careviso, a healthcare technology company and market leader in molecular diagnostic patient access technology (the “Company”), today announced that it has raised over $17 million in Series B funding led by Ballast Point Ventures with participation from existing investors Mercury and Lytical Ventures. The new funding will enable careviso to broadly expand its existing technology platform into the diagnostic space providing patients with clarity around their cost of care while reducing administrative burdens for physicians.

Company Information

Company

careviso (Formerly CMT Solutions)

Location

7600 Leesburg Pike

Falls Church, Virginia, United States

About

careviso is a healthcare technology company. By automating the impossible we’re able to solve the most complex problems in the healthcare industry in real-time: prior authorizations and financial transparency. careviso created a complete technology platform that increases patient access to care by delivering cost estimates, administrative requirements and approvals in real time. careviso began with a laboratory focused approach, and our mission is to support patients, providers, and payors with total access to healthcare.

FundzWatch™ Score

Medium Activity

Buyer Intent Analysis

Get personalized insights on buying likelihood

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech